The New England Journal of Medicine

Original Article

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer

Matthew R. Smith, M.D., Ph.D., Blair Egerdie, M.D., Narciso Hernández Toriz, M.D., Robert Feldman, M.D., Teuvo L.J. Tammela, M.D., Fred Saad, M.D., Jiri Heracek, M.D., Ph.D., Maciej Szwedowski, M.D., Chunlei Ke, Ph.D., Amy Kupic, M.A., Benjamin Z. Leder, M.D., and Carsten Goessl, M.D. for the Denosumab HALT Prostate Cancer Study Group

N Engl J Med 2009; 361:745-755August 20, 2009